leisure time -WSS

leisure time

author：leisure time 2025-10-03 00:38:24 - browse：3

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： Medical records are filled with copy
Next article： Target recalls 2.2 million additional candles due to laceration, burn hazards

hotspot

WSS

A rare thyroid diagnosis led to unexpected, all

Crinetics acromegaly drug succeeds in late

Kim Kardashian sparks debate on benefits of full

What American doctors can learn from their Israeli counterparts

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Some of the ways extreme heat will change life as we know it

entertainment

leisure time

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Where are patients getting their prescriptions for GLP

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

United colonoscopy coverage change 'may cost lives,' doctors say

Novo acquires Inversago for up to $1 billion

Tori Bowie and the unacceptable rates of Black maternal death

Medicaid rebukes states for mistakenly disenrolling children

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

focus

GOP presidential candidates start declaring their loyalty

TB outbreak tied to bone grafts underscores testing shortcomings

House transparency, PBM reform bill gains bipartisan support

Who are the detained American citizens released from prison in Iran?

Newly revealed memo details efforts to keep Trump in power following election loss

Genentech weighs delaying cancer therapy after drug pricing law

leisure time

hotspot

focus

leisure time